Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	47	49	22	79	70	132
Market Cap Growth	512.80%	119.94%	-71.84%	13.36%	-47.12%	-47.70%
Enterprise Value	35	34	10	47	61	88
PE Ratio	-	-5.94	-0.74	-1.88	-2.43	-6.14
PS Ratio	14.07	14.77	6.33	63.58	149.18	617.67
PB Ratio	3.96	3.48	1.13	1.80	2.55	2.99
P/FCF Ratio	-2.68	-2.97	-0.82	-2.60	-2.38	-7.06
P/OCF Ratio	-2.66	-2.97	-0.82	-2.89	-3.48	-7.20
EV/Sales Ratio	10.66	10.20	2.97	38.10	129.70	414.01
EV/EBITDA Ratio	-4.07	-4.10	-0.35	-1.22	-2.19	-4.17
EV/EBIT Ratio	-4.76	-4.10	-0.35	-1.13	-2.11	-4.12
EV/FCF Ratio	-1.89	-2.05	-0.39	-1.56	-2.07	-4.73
Debt / Equity Ratio	-	-	-	0.27	0.45	0.01
Debt / EBITDA Ratio	-	-	-	-0.31	-0.44	-0.02
Debt / FCF Ratio	-	-	-	-0.39	-0.42	-0.03
Quick Ratio	5.72	5.25	1.82	3.37	3.49	22.03
Current Ratio	6.12	5.57	2.14	3.56	3.81	22.83
Asset Turnover	0.18	0.15	0.08	0.02	0.01	0.00
Return on Equity (ROE)	-36.80%	-50.10%	-113.00%	-72.20%	-87.00%	-43.10%
Return on Assets (ROA)	-31.20%	-38.10%	-65.50%	-54.20%	-61.90%	-40.50%
Return on Capital (ROIC)	-108.76%	-103.76%	-100.97%	-70.68%	-72.94%	-50.55%
Earnings Yield	-12.11%	-16.85%	-134.65%	-53.05%	-41.22%	-16.27%
FCF Yield	-30.55%	-33.63%	-121.34%	-38.52%	-42.06%	-14.17%
Buyback Yield / Dilution	-2.07%	-5.49%	-9.16%	-62.64%	-3.19%	-138.78%
Total Shareholder Return	-2.07%	-5.49%	-9.16%	-62.64%	-3.19%	-138.78%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).